Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dobutamine to improve intracranial perfusion in lacunar ischemic stroke
MOH_2023-11-06_013033Phase 3Not yet recruiting
- Sponsor
- ד"ר סטפן מאוסבך
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of dobutamine in ischemic stroke and lacunar infarct, sponsored by ד"ר סטפן מאוסבך. Planned start Oct 2023; status: not yet recruiting.
02
Drugs
dobutamine
03
Conditions
ischemic strokelacunar infarct
Beyond the preview
Go deeper on MOH_2023-11-06_013033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2023-11-06_013033.